Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
StimScience
AddedFeb 15, 2024
UpdatedJun 18, 2026
StimScience

StimScience

Seed

StimScience, a neurotech firm, innovates in electroceuticals, specializing in diverse tES and custom waveform creation.

HQ
Berkeley, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

StimScience is an Electroceuticals company that develops all common types of tES including transcranial direct current stimulation, transcranial alternating current stimulation, transcranial random noise stimulation.

The company's NeuroMod tXES system allows the user to create any arbitrary waveform... Read more

StimScience - Similar Companies

neusleep logo

neusleep

neusleep.co

Epic Neuro logo

Epic Neuro

Actipulse Neuroscience logo

Actipulse Neuroscience

electroCore logo

electroCore

Attune Neurosciences logo

Attune Neurosciences

attuneneuro.com

Realeve logo

Realeve

StimAire logo

StimAire

stimaire.com

Nexalin Technology logo

Nexalin Technology

NeuroSigma logo

NeuroSigma

neurosigma.com

Neuronetics logo

Neuronetics

neurostar.com

Cervel Neurotech logo

Cervel Neurotech

cervel.com

Soterix Medical logo

Soterix Medical

soterixmedical.com

Scion Neurostim logo

Scion Neurostim

scionneurostim.com

Highland Instruments logo

Highland Instruments

eNeura Therapeutics logo

eNeura Therapeutics

eneura.com

StimScience - Quick Facts

Who are StimScience's competitors?

Companies similar to StimScience include neusleep, Epic Neuro, Actipulse Neuroscience and electroCore.

When was StimScience founded?

StimScience was founded in 2017.

Where is StimScience's headquarters located?

StimScience's headquarters is located in Berkeley, CA, US.

When was StimScience's last funding round?

StimScience's most recent funding round was for $6M (USD) in April 2021.

How much has StimScience raised to-date?

As of Apr 5, 2021, StimScience has raised a total of $6M (USD).

How many employees does StimScience have?

StimScience has 16 employees as of Feb 4, 2024.

StimScience - Classification

Ownership
  • Venture Capital
Technology
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
Main Product
  • Sleep Technology
Tags
  • Hardware
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified